Wound Bacterial Microbiota and Their Antibiotic Resistance
1 other identifier
observational
457
1 country
1
Brief Summary
The purpose of the study is to explore the microbiology in war-associated wounds of hospitalized patients from the Syrian armed conflict. Cultures collected from acute wounds with clinical signs of infection will be analyzed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2014
CompletedFirst Submitted
Initial submission to the registry
April 13, 2016
CompletedFirst Posted
Study publicly available on registry
April 20, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2016
CompletedJune 1, 2017
May 1, 2017
1.8 years
April 13, 2016
May 31, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Proportion of patients that develops infections after receiving surgical treatment
30 days
Secondary Outcomes (5)
Frequency of different bacterial microbiota in wounds with clinical signs of infection
30 days
Frequency of microbiota with antibiotic resistance in wounds with clinical signs of infection
30 days
Length of stay
30 days
Surgery
30 days
Death
30 days
Study Arms (2)
Non-infection
Patients without clinical infection or positive wound culture
Infection
Patients with clinical infection and positive wound culture
Eligibility Criteria
Patients originating from the Syrian armed conflict who receive treatment for blast- and gunshot-injuries.
You may qualify if:
- Patients that receive surgical treatment for war-associated injuries, irrespective of injury location, injury mechanism, time from injury and prior treatment
- Patients that receive treatment during the study period and are later re-admitted will only be counted as one patient
You may not qualify if:
- Patients that are only re-admitted during the study period, i.e. patients that received primary treatment by MSF before study initiation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Karolinska Institutetlead
- Medecins Sans Frontieres, Netherlandscollaborator
Study Sites (1)
Ministry of Health hospital
Ar Ramtha, Irbid Governorate, Jordan
Related Publications (11)
Fares Y, El-Zaatari M, Fares J, Bedrosian N, Yared N. Trauma-related infections due to cluster munitions. J Infect Public Health. 2013 Dec;6(6):482-6. doi: 10.1016/j.jiph.2013.05.006. Epub 2013 Jul 31.
PMID: 23999350BACKGROUNDCovey DC, Lurate RB, Hatton CT. Field hospital treatment of blast wounds of the musculoskeletal system during the Yugoslav civil war. J Orthop Trauma. 2000 May;14(4):278-86; discussion 277. doi: 10.1097/00005131-200005000-00010.
PMID: 10898201BACKGROUNDTong MJ. Septic complications of war wounds. JAMA. 1972 Feb 21;219(8):1044-7. No abstract available.
PMID: 4621762BACKGROUNDMurray CK. Infectious disease complications of combat-related injuries. Crit Care Med. 2008 Jul;36(7 Suppl):S358-64. doi: 10.1097/CCM.0b013e31817e2ffc.
PMID: 18594263BACKGROUNDGiannou C, Baldan M. War Surgery: Working With Limited Resources in Armed Conflict and Other Situations of Violence. ICRC; 2010.
BACKGROUNDMurray CK, Hsu JR, Solomkin JS, Keeling JJ, Andersen RC, Ficke JR, Calhoun JH. Prevention and management of infections associated with combat-related extremity injuries. J Trauma. 2008 Mar;64(3 Suppl):S239-51. doi: 10.1097/TA.0b013e318163cd14.
PMID: 18316968BACKGROUNDTeicher CL, Ronat JB, Fakhri RM, Basel M, Labar AS, Herard P, Murphy RA. Antimicrobial drug-resistant bacteria isolated from Syrian war-injured patients, August 2011-March 2013. Emerg Infect Dis. 2014 Nov;20(11):1949-51. doi: 10.3201/eid2011.140835. No abstract available.
PMID: 25340505BACKGROUNDSutter DE, Bradshaw LU, Simkins LH, Summers AM, Atha M, Elwood RL, Robertson JL, Murray CK, Wortmann GW, Hospenthal DR. High incidence of multidrug-resistant gram-negative bacteria recovered from Afghan patients at a deployed US military hospital. Infect Control Hosp Epidemiol. 2011 Sep;32(9):854-60. doi: 10.1086/661284.
PMID: 21828965BACKGROUNDDau AA, Tloba S, Daw MA. Characterization of wound infections among patients injured during the 2011 Libyan conflict. East Mediterr Health J. 2013 Apr;19(4):356-61.
PMID: 23882961BACKGROUNDEardley WG, Brown KV, Bonner TJ, Green AD, Clasper JC. Infection in conflict wounded. Philos Trans R Soc Lond B Biol Sci. 2011 Jan 27;366(1562):204-18. doi: 10.1098/rstb.2010.0225.
PMID: 21149356BACKGROUNDAlga A, Wong S, Shoaib M, Lundgren K, Giske CG, von Schreeb J, Malmstedt J. Infection with high proportion of multidrug-resistant bacteria in conflict-related injuries is associated with poor outcomes and excess resource consumption: a cohort study of Syrian patients treated in Jordan. BMC Infect Dis. 2018 May 22;18(1):233. doi: 10.1186/s12879-018-3149-y.
PMID: 29788910DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jonas Malmstedt, MD, PhD
Karolinska Institutet
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- co-pi
Study Record Dates
First Submitted
April 13, 2016
First Posted
April 20, 2016
Study Start
September 1, 2014
Primary Completion
June 1, 2016
Study Completion
June 1, 2016
Last Updated
June 1, 2017
Record last verified: 2017-05